Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.34 - $9.53 $792,151 - $1.19 Million
-124,945 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$8.16 - $11.33 $1.43 Million - $1.98 Million
-175,055 Reduced 58.35%
124,945 $1.13 Million
Q4 2021

Feb 14, 2022

BUY
$10.38 - $15.2 $674,700 - $988,000
65,000 Added 27.66%
300,000 $3.37 Million
Q3 2021

Nov 17, 2021

SELL
$13.6 - $17.88 $884,000 - $1.16 Million
-65,000 Reduced 21.67%
235,000 $3.44 Million
Q3 2021

Nov 15, 2021

BUY
$13.6 - $17.88 $1.22 Million - $1.6 Million
89,720 Added 42.67%
300,000 $4.03 Million
Q2 2021

Aug 13, 2021

BUY
$16.0 - $20.59 $1.34 Million - $1.73 Million
83,853 Added 66.33%
210,280 $3.44 Million
Q1 2021

May 06, 2021

BUY
$19.16 - $28.09 $2.42 Million - $3.55 Million
126,427 New
126,427 $2.55 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.